GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 22 filers reported holding GAIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 123,000 | $385 | 0.61% |
| CM Management, LLC | 110,000 | $344 | 0.41% |
| Greenlight Capital | 546,560 | $1,710,732 | 0.12% |
| Wealth Alliance Advisory Group, LLC | 18,751 | $58,691 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $181,853 | 0.01% |
| Cannell Capital | 12,371 | $38,721 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $187,800 | 0.01% |
| HOEY INVESTMENTS, INC | 500 | $1,565 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 12,742 | $39,882 | 0.00% |
| Tower Research Capital LLC (TRC) | 7,152 | $23 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 90,114 | $282 | 0.00% |
| MORGAN STANLEY | 800 | $2,504 | 0.00% |
| BlackRock Inc. | 24,980 | $78,188 | 0.00% |
| Renaissance Technologies | 33,200 | $104 | 0.00% |
| ROYAL BANK OF CANADA | 39,000 | $122,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 24,000 | $75,120 | 0.00% |
| UBS Group AG | 7,289 | $22,815 | 0.00% |
| OSAIC HOLDINGS, INC. | 10,000 | $31,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,946 | $37 | 0.00% |
External links
This page lists GAIN THERAPEUTICS INC's shareholders in Q4 2022. To view GAIN THERAPEUTICS INC's shareholder history, click here.